HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study

References

• Spino C, Kahn JO, Dolin R, et al. Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):346–355. doi:10.1097/00042560-199708150-00004
   PubMedGoogle Scholar
• Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang L, Hou Y, et al. Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study. Emerg Microbes Infect. 2020 Dec;9(1):2550–2561. doi:10.1080/22221751.2020.1840928
   PubMed Web of Science ®Google Scholar
• AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention. Chinese guidelines for the diagnosis and treatment of HIV/AIDS (2021 edition). Infectious Diseases & Immunity. 2022 Jul 20;02(03):145–167.
   Google Scholar
• Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. Br Med J. 2009 Jan 26;338:a3172. doi:10.1136/bmj.a3172
   PubMed Web of Science ®Google Scholar
• Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Young J, Psichogiou M, et al. CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med. 2012;9(3):e1001194. doi:10.1371/journal.pmed.1001194
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Rother C, Salih W, et al. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis. 2014 Feb;58(3):330–339. doi:10.1093/cid/cit734
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S, Sainz T, Lee SA, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014 May;10(5):e1004078. doi:10.1371/journal.ppat.1004078
   PubMed Web of Science ®Google Scholar
• Okulicz JF, Le TD, Agan BK, et al. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals. JAMA Intern Med. 2015 Jan;175(1):88–99. doi:10.1001/jamainternmed.2014.4010
   PubMed Web of Science ®Google Scholar
• Mussini C, Lorenzini P, Cozzi-Lepri A, et al. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV. 2015 Mar;2(3):e98–106. doi:10.1016/S2352-3018(15)00006-5
   PubMed Web of Science ®Google Scholar
• Roul H, Mary-Krause M, Ghosn J, et al. CD4 + cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era. AIDS. 2018 Nov 13;32(17):2605–2614. doi:10.1097/QAD.0000000000002010
   PubMed Web of Science ®Google Scholar
• Cao W, Liu X, Han Y, et al. (5r)−5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study. Lancet Reg Health West Pac. 2023;34:100724.
   PubMedGoogle Scholar
• Zaongo SD, Chen Y. Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders. Chin Med J (Engl). 2023 Sep 20;136(18):2147–2155. doi:10.1097/CM9.0000000000002493
   PubMed Web of Science ®Google Scholar
• Hassett JM, Zaroulis CG, Greenberg ML, et al. Bone-marrow transplantation in AIDS. N Engl J Med. 1983 Sep 15;309(11):665.
   PubMed Web of Science ®Google Scholar
• Lane HC, Masur H, Longo DL, et al. Partial immune reconstitution in a patient with the acquired immunodeficiency syndrome. N Engl J Med. 1984 Oct 25;311(17):1099–1103. doi:10.1056/NEJM198410253111706
   PubMed Web of Science ®Google Scholar
• Vilmer E, Rhodes-Feuillette A, Rabian C, et al. Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation. 1987 Jul;44(1):25–29. doi:10.1097/00007890-198707000-00007
   PubMed Web of Science ®Google Scholar
• Holland HK, Saral R, Rossi JJ, et al. Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med. 1989 Dec 15;111(12):973–981. doi:10.7326/0003-4819-111-12-973
   PubMed Web of Science ®Google Scholar
• Tebas P, Stein D, Tang WW, et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med. 2014 Mar 6;370(10):901–910. doi:10.1056/NEJMoa1300662
   PubMed Web of Science ®Google Scholar
• Xu L, Wang J, Liu Y, et al. CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia. N Engl J Med. 2019 Sep 26;381(13):1240–1247. doi:10.1056/NEJMoa1817426
   PubMed Web of Science ®Google Scholar
• Hütter G, Ganepola S, Schneider T, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009;360(7):692–698. doi:10.1056/NEJMoa0802905
   PubMed Web of Science ®Google Scholar
• Gupta RK, Abdul-Jawad S, McCoy LE, et al. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation. Nature. 2019 Apr;568(7751):244–248. doi:10.1038/s41586-019-1027-4
   PubMed Web of Science ®Google Scholar
• Jensen BEO, Knops E, Cords L, et al. In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation. Nat Med. 2023 Mar;29(3):583–587. doi:10.1038/s41591-023-02213-x
   PubMed Web of Science ®Google Scholar
• Huang XJ. Current status of haploidentical stem cell transplantation for leukemia. J Hematol Oncol. 2008;1:27. doi:10.1186/1756-8722-1-27
   PubMed Web of Science ®Google Scholar
• McCurdy SR, Kanakry JA, Showel MM, et al. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 2015;125(19):3024–3031. doi:10.1182/blood-2015-01-623991
   PubMed Web of Science ®Google Scholar
• Kong Y, Wang Y, Zhang YY, et al. Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation. Blood Adv. 2019;3(8):1303–1317. doi:10.1182/bloodadvances.2018029454
   PubMed Web of Science ®Google Scholar
• Guo M, Hu KX, Yu CL, et al. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood. 2011;117(3):936–941. doi:10.1182/blood-2010-06-288506
   PubMed Web of Science ®Google Scholar
• Guo M, Hu KX, Liu GX, et al. HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up. J Clin Oncol. 2012;30(33):4084–4090. doi:10.1200/JCO.2012.42.0281
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang JY, Tu B, et al. HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients. Sig Transduct Target Ther. 2021 May 7;6(1):174. doi:10.1038/s41392-021-00550-2
   PubMed Web of Science ®Google Scholar
• AIDS and Hepatitis C Professional Group. Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention. Zhonghua Nei Ke Za Zhi. 2018;57(12):867–884.
   PubMedGoogle Scholar
• AIDS and Hepatitis C Professional Group. Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention. Zhonghua Nei Ke Za Zhi. 2021;60(12):1106–1128.
   PubMedGoogle Scholar
• Global HIV & AIDS statistics — Fact sheet [Internet]. [cited 2024 Mar 3]. Available from: https://www.unaids.org/en/resources/fact-sheet.
   Google Scholar
• Vlahov D, Graham N, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA. 1998 Jan 7;279(1):35–40. doi:10.1001/jama.279.1.35
   PubMed Web of Science ®Google Scholar
• Dickter JK, Aribi A, Cardoso AA, et al. HIV-1 Remission after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2024 Feb 15;390(7):669–671. doi:10.1056/NEJMc2312556
   PubMed Web of Science ®Google Scholar
• Shearer GM, Clerici M, Graham DR, et al. Curing HIV/AIDS beyond hematopoietic stem cell transplant. AIDS. 2015 Nov;29(17):2364–2366. doi:10.1097/QAD.0000000000000861
   PubMed Web of Science ®Google Scholar
• Wang Y, Tao L, Mitchell E, et al. Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat Med. 1999 Sep;5(9):1004–1009. doi:10.1038/12440
   PubMed Web of Science ®Google Scholar
• Durand CM, Capoferri AA, Redd AD, et al. Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study. Lancet HIV. 2020 Sep;7(9):e602–e610. doi:10.1016/S2352-3018(20)30073-4
   PubMed Web of Science ®Google Scholar
• Melenhorst JJ, Leen AM, Bollard CM, et al. Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood. 2010;116(22):4700–4702. doi:10.1182/blood-2010-06-289991
   PubMed Web of Science ®Google Scholar
• INSIGHT-ESPRIT Study Group, SILCAAT Scientific Committee, Abrams D, et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 2009 Oct 15;361(16):1548–1559. doi:10.1056/NEJMoa0903175
   PubMed Web of Science ®Google Scholar
• Lévy Y, Sereti I, Tambussi G, et al. Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clin Infect Dis. 2012 Jul;55(2):291–300. doi:10.1093/cid/cis383
   PubMed Web of Science ®Google Scholar
• Vandergeeten C, Fromentin R, DaFonseca S, et al. Interleukin-7 promotes HIV persistence during antiretroviral therapy. Blood. 2013 May 23;121(21):4321–4329. doi:10.1182/blood-2012-11-465625
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu DP, Liu QF, et al. Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants. Leukemia. 2018 Feb;32(2):492–498. doi:10.1038/leu.2017.199
   PubMed Web of Science ®Google Scholar
• Miklos DB, Kim HT, Miller KH, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 2005 Apr 1;105(7):2973–2978. doi:10.1182/blood-2004-09-3660
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Z, Lu X, et al. Dysregulation of memory B cells and circulating T follicular helper cells is a predictor of poor immune recovery in HIV-infected patients on antiretroviral therapy. J Med Virol. 2023;95(2):e28559. doi:10.1002/jmv.28559
   PubMed Web of Science ®Google Scholar
• Yang X, Su B, Zhang X, et al. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: challenges of immunological non-responders. J Leukoc Biol. 2020;107(4):597–612. doi:10.1002/JLB.4MR1019-189R
   PubMed Web of Science ®Google Scholar
• Su B, Kong D, Yang X, et al. Mucosal-associated invariant T cells: a cryptic coordinator in HIV-infected immune reconstitution. J Med Virol. 2022;94(7):3043–3053. doi:10.1002/jmv.27696
   PubMed Web of Science ®Google Scholar